Get started
Author

Kazuomi Ueshima

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
2019 · Masatoshi Kudo, Kazuomi Ueshima, et al. · Gut · 722
PDF
Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update
2021 · Masatoshi Kudo, Yusuke Kawamura, et al. · Liver Cancer · 678
JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan
2014 · Masatoshi Kudo, Osamu Matsui, et al. · Liver Cancer · 615
Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child–Pugh A Liver Function: A Proof-Of-Concept Study
2019 · Masatoshi Kudo, Kazuomi Ueshima, et al. · Cancers · 309
PDF
Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines)
2023 · Kiyoshi Hasegawa, Nobuyuki Takemura, et al. · Hepatology Research · 300
Transarterial Chemoembolization Failure/Refractoriness: JSH-LCSGJ Criteria 2014 Update
2014 · Masatoshi Kudo, Osamu Matsui, et al. · Oncology · 283
Subclassification of BCLC B Stage Hepatocellular Carcinoma and Treatment Strategies: Proposal of Modified Bolondi's Subclassification (Kinki Criteria)
2015 · Masatoshi Kudo, Tadaaki Arizumi, et al. · Digestive Diseases · 226
Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma
2015 · Tadaaki Arizumi, Kazuomi Ueshima, et al. · Liver Cancer · 207
Achievement of Complete Response and Drug-Free Status by Atezolizumab plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Proof-Of-Concept Study
2023 · Masatoshi Kudo, Tomoko Aoki, et al. · Liver Cancer · 160
PDF
Differential Diagnosis of Hepatic Tumors: Value of Contrast-Enhanced Harmonic Sonography Using the Newly Developed Contrast Agent, Sonazoid
2008 · Kinuyo Hatanaka, Masatoshi Kudo, et al. · Intervirology · 151
FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma
2012 · Tokuzo Arao, Kazuomi Ueshima, et al. · Hepatology · 150
PDF
Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarterial Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma
2022 · Masatoshi Kudo, Kazuomi Ueshima, et al. · Liver Cancer · 141
Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Study
2019 · Kazuomi Ueshima, Naoshi Nishida, et al. · Cancers · 140
PDF
Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis
2022 · M. Rimini, L. Rimassa, et al. · ESMO Open · 128
PDF
Reactive Oxygen Species Induce Epigenetic Instability through the Formation of 8-Hydroxydeoxyguanosine in Human Hepatocarcinogenesis
2013 · Naoshi Nishida, Tadaaki Arizumi, et al. · Digestive Diseases · 113
Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
2020 · Kazuomi Ueshima, Sadahisa Ogasawara, et al. · Liver Cancer · 112
PDF
Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinoma
2012 · S Hagiwara, M Kudo, et al. · British Journal of Cancer · 109
PDF
Noninvasive Evaluation of Hepatic Fibrosis Using Serum Fibrotic Markers, Transient Elastography (FibroScan) and Real-Time Tissue Elastography
2008 · Chie Tatsumi, Masatoshi Kudo, et al. · Intervirology · 109
A Phase 2, Prospective, Multicenter, Single-Arm Trial of Transarterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Intermediate-Stage Hepatocellular Carcinoma: TACTICS-L Trial
2023 · Masatoshi Kudo, Kazuomi Ueshima, et al. · Liver Cancer · 105
Hepatic Arterial Infusion Chemotherapy Using Low-Dose 5-Fluorouracil and Cisplatin for Advanced Hepatocellular Carcinoma
2010 · Kazuomi Ueshima, Masatoshi Kudo, et al. · Oncology · 100
Initial Treatment Response Is Essential to Improve Survival in Patients with Hepatocellular Carcinoma Who Underwent Curative Radiofrequency Ablation Therapy
2007 · Shunsuke Takahashi, Masatoshi Kudo, et al. · Oncology · 97
Positioning of a Molecular-Targeted Agent, Sorafenib, in the Treatment Algorithm for Hepatocellular Carcinoma and Implication of Many Complete Remission Cases in Japan
2010 · Masatoshi Kudo, Kazuomi Ueshima · Oncology · 93
Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT
2012 · Tatsuo Inoue, Masatoshi Kudo, et al. · Journal of Gastroenterology · 90
Immunological Microenvironment Predicts the Survival of the Patients with Hepatocellular Carcinoma Treated with Anti-PD-1 Antibody
2021 · Masahiro Morita, Naoshi Nishida, et al. · Liver Cancer · 86
B-Mode Ultrasonography versus Contrast-Enhanced Ultrasonography for Surveillance of Hepatocellular Carcinoma: A Prospective Multicenter Randomized Controlled Trial
2019 · Masatoshi Kudo, Kazuomi Ueshima, et al. · Liver Cancer · 85
PDF
Works count: 410
Citation count: 8,707
H-index: 45
I10-index: 128
Year
Topic
Type